Jump to content

Radiation Oncology/Prostate/Guidelines

Add links
From Wikibooks, open books for an open world


Prostate Cancer Guidelines

General

[edit | edit source]
  • NCCN: Prostate Cancer
  • NCI: Health Professional PDQ
  • ACR: Prostate Main Page
  • AUA: Clinically Localized Prostate Cancer
    • Guideline link
    • 2007 PMID 17509297 -- "Guideline for the management of clinically localized prostate cancer: 2007 update." (Thompson I, J Urol. 2007 Jun;177(6):2106-31.)
  • NICE: Summary of NICE guidance
    • Guideline link
    • 2008 PMID 18340076 -- "Diagnosis and treatment of prostate cancer: summary of NICE guidance." (Graham J, BMJ. 2008 Mar 15;336(7644):610-2.)
  • EAU: European Association of Urology
  • ESMO: European Society for Medical Oncology
    • 2012 PMID 23303340 link -- "Prostate cancer: ESMO Consensus Conference Guidelines 2012"

Screening

[edit | edit source]
  • ACS: Prostate Cancer: Early Detection
    • Guideline link
    • 2010 PMID 20200110 -- "American Cancer Society guideline for the early detection of prostate cancer: update 2010." (Wolf AM, CA Cancer J Clin. 2010 Mar-Apr;60(2):70-98. Epub 2010 Mar 3.)


Pretreatment Staging

[edit | edit source]


General Radiation Therapy

[edit | edit source]
  • German S3: Localized and Locally Advanced Prostate Cancer
    • 2010 PMID 20180061 -- "[Radiation therapy for prostate cancer in the new S3 guideline. Part 1: localized and locally advanced prostate cancer] [Article in German]" (Bohmer D, Urologe A. 2010 Feb;49(2):211-5.)
  • German S3: Postoperative Radiation Therapy and Brachytherapy
    • 2010 PMID 20180062 -- "[Radiation therapy for prostate cancer in the new S3 guideline. Part 2: postoperative radiation therapy and brachytherapy] [Article in German]" (Martin T, Urologe A. 2010 Feb;49(2):216-20.)
  • ACR: Definitive EBRT for Stage T1-T2
  • ACR: EBRT Treatment Planning

Hormonal Therapy

[edit | edit source]
  • ASCO:
    • 2006 PMID 17404365 -- Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline
    • 2004 PMID 15184404 -- American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer

Locally Advanced Prostate Cancer

[edit | edit source]


Node Positive Prostate Cancer

[edit | edit source]


Adjuvant RT

[edit | edit source]


Salvage RT

[edit | edit source]
  • ASTRO: Guidelines for re-biopsy and rising PSA after RP
    • 1999 PMID 10561174 Full text -- Guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy

Active Surveillance

[edit | edit source]
  • ASCO / Cancer Care Ontario
    • 2016 PMID 26884580 -- "Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement." (Chen R, J Clin Oncol. 2016 Feb 16 -- online ahead of print)

Permanent Brachytherapy

[edit | edit source]
  • ACR: Permanent Source Brachytherapy
    • Guideline link
    • 2010 PMID 21106306 -- "American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the transperineal permanent brachytherapy of prostate cancer." (Rosenthal SA, Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):335-41. Epub 2010 Nov 23.)
  • ABS: Low dose-rate guidelines
    • Guideline link (may be out of date)
    • 2012 PMID 22265434 -- "American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy."
    • Morbidity; 2002 PMID 12243823 — "American Brachytherapy Society recommendations for reporting morbidity after prostate brachytherapy." (Nag S et al. Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):462-70.)
    • 103Pd; 2000 PMID 10802349 — "American brachytherapy society recommendations for clinical implementation of NIST-1999 standards for (103)palladium brachytherapy. The clinical research committee of the American Brachytherapy Society." (Beyer D et al. Int J Radiat Oncol Biol Phys. 2000 May 1;47(2):273-5.)
    • Postimplant Dosimetry; 2000 PMID 10656396 — "The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis." (Nag S et al. Int J Radiat Oncol Biol Phys. 2000 Jan 1;46(1):221-30.)
    • Transperineal; 1999 PMID 10386635 — "American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer." (Nag S et al. Int J Radiat Oncol Biol Phys. 1999 Jul 1;44(4):789-99.)
  • ABS: High dose-rate guidelines
    • Guideline link (may be out of date)
    • 2012 PMID 22265435 -- "American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy."
  • Cesium Advisory Group: Permanent prostate brachytherapy with Cs-131
    • Cesium; 2008 PMID 18782682 -- "Recommendations for permanent prostate brachytherapy with (131)Cs: a consensus report from the Cesium Advisory Group." (Bice WS, Brachytherapy. 2008 Oct-Dec;7(4):290-6. Epub 2008 Sep 7.)
  • NICE: Low dose-rate brachytherapy

Contouring

[edit | edit source]

Cryotherapy

[edit | edit source]


High-intensity focused ultrasound

[edit | edit source]


Hormone refractory prostate cancer

[edit | edit source]


Toxicity

[edit | edit source]
Retrieved from "https://en.wikibooks.org/w/index.php?title=Radiation_Oncology/Prostate/Guidelines&oldid=3052040"